Contact
searchSearch
HMP Global

Ulcerative Colitis Videos

David Rubin
Conference Coverage
David Rubin, MD, on Positioning Therapies and Improving Outcomes in Ulcerative Colitis
10/23/2026
David T. Rubin, MD
Dr Rubin presents the key takeaways from his lecture on positioning therapies for ulcerative colitis to optimize outcomes, which he delivered at the ACG Postgraduate Course in Nashville. 
Dr Rubin presents the key takeaways from his lecture on positioning therapies for ulcerative colitis to optimize outcomes, which he delivered at the ACG Postgraduate Course in Nashville. 
Dr Rubin presents the key...
10/23/2026
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
David Rubin, MD, on Histologic Outcomes of QUASAR Extension Study
10/13/2026
David T. Rubin, MD
Dr Rubin reviews data from the QUASAR phase 3 trial of guselkumab in patients with ulcerative colitis, specifically looking at histologic remission, which he presented at the ACG Scientific Meeting in Nashville.
Dr Rubin reviews data from the QUASAR phase 3 trial of guselkumab in patients with ulcerative colitis, specifically looking at histologic remission, which he presented at the ACG Scientific Meeting in Nashville.
Dr Rubin reviews data from the...
10/13/2026
Advances in Inflammatory Bowel Disease Network
Maria Abreu
Research Insights
Maria Abreu, MD, on the DUET-UC Trial of Combination Therapy
05/19/2026
Maria Abreu, MD
Dr Abreu recaps the results of a late breaking abstract from Digestive Disease Week on the DUET-UC study, which tested whether a combination of two advanced therapies showed an additive or synergistic effect in patients refractory ulcerative...
Dr Abreu recaps the results of a late breaking abstract from Digestive Disease Week on the DUET-UC study, which tested whether a combination of two advanced therapies showed an additive or synergistic effect in patients refractory ulcerative...
Dr Abreu recaps the results of a...
05/19/2026
Advances in Inflammatory Bowel Disease Network
Jean-Frederic Colombel
Expert Insights
Jean-Frederic Colombel, MD, on Disease Clearance With Mirikizumab in Ulcerative Colitis
05/06/2026
Jean-Frederic Colombel
Dr Colombel discusses his presentation at DDW 2026 on a post-doc analysis of the long-term outcomes of the LUCENT trial of mirikizumab, which showed that the IL-23p19 inhibitor achieved and maintained disease clearance for up to 4 years among...
Dr Colombel discusses his presentation at DDW 2026 on a post-doc analysis of the long-term outcomes of the LUCENT trial of mirikizumab, which showed that the IL-23p19 inhibitor achieved and maintained disease clearance for up to 4 years among...
Dr Colombel discusses his...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Millie Long
Conference Coverage
Millie Long, MD, on Updates in the Management of Ulcerative Colitis
11/27/2025
Millie D. Long, MD, MPH
Dr Long reviews key points from her presentation from the AIBD regional meetings on new therapies for managing ulcerative colitis.
Dr Long reviews key points from her presentation from the AIBD regional meetings on new therapies for managing ulcerative colitis.
Dr Long reviews key points from...
11/27/2025
Advances in Inflammatory Bowel Disease Network
Vipul Jairath
Conference Coverage
Vipul Jairath, MBChB, on the ANTHEM Study of Icotrokinra in UC
11/05/2025
Vipul Jairath, MD
Dr Jairath discusses the phase 2B study results of icotrokinra, a novel, oral interleukin-23 peptide, for the treatment of moderately to severely active ulcerative colitis, which were presented at the ACG 2025 Scientific Meeting.
Dr Jairath discusses the phase 2B study results of icotrokinra, a novel, oral interleukin-23 peptide, for the treatment of moderately to severely active ulcerative colitis, which were presented at the ACG 2025 Scientific Meeting.
Dr Jairath discusses the phase...
11/05/2025
Advances in Inflammatory Bowel Disease Network
Maia Kayal
Video
Maia Kayal MD, on Strategies for Managing Patients When Mesalamine Fails
12/27/2024
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options...
12/27/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Conference coverage
Millie Long, MD, on Defining Disease Severity in Ulcerative Colitis
12/16/2024
Millie D. Long, MD, MPH
Dr Millie Long discusses the difference between the "snapshot" of disease activity and the "movie" of disease severity, and the importance of carefully assessing severity when choosing therapies and developing monitoring strategies for...
Dr Millie Long discusses the difference between the "snapshot" of disease activity and the "movie" of disease severity, and the importance of carefully assessing severity when choosing therapies and developing monitoring strategies for...
Dr Millie Long discusses the...
12/16/2024
Advances in Inflammatory Bowel Disease Network
Video
Maria Abreu, MD, on When the First Advanced Therapy Fails in UC
12/09/2024
Maria Abreu, MD
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first...
12/09/2024
Advances in Inflammatory Bowel Disease Network
Corey Siegel
Video
Corey Siegel, MD, on Shared Decision-Making in Ulcerative Colitis
12/06/2024
Dr Siegel, from Dartmouth-Hitchcock Medical Center in New Hampshire, reviews the importance of shared decision-making, careful listening, and providing guidance in developing treatment plans for patients with ulcerative colitis.
Dr Siegel, from Dartmouth-Hitchcock Medical Center in New Hampshire, reviews the importance of shared decision-making, careful listening, and providing guidance in developing treatment plans for patients with ulcerative colitis.
Dr Siegel, from...
12/06/2024
Advances in Inflammatory Bowel Disease Network

About Us

The Advances in Inflammatory Bowel Disease Network provides gastroenterology professionals with a central source for the wealth of content on IBD—articles, abstracts, videos, podcasts, and commentary—generated at our regional and annual meetings.

Learn more about our event and register here:

AIBD logo

Latest Podcasts

IBD Drive time logo
Expert Insights
IBD Drive Time: Adam Faye, MD, on Managing IBD in Special Populations
11/03/2026
Raymond Cross, MD; Adam Faye, MD, MS
Drs Adam Faye and Raymond Cross discuss the particular issues to consider when treating patients who are older, obese, or frail, as well as patients with a history of or current cancer or heart disease.
Drs Adam Faye and Raymond Cross discuss the particular issues to consider when treating patients who are older, obese, or frail, as well as patients with a history of or current cancer or heart disease.
Drs Adam Faye and Raymond Cross...
11/03/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Sara Horst, MD, on Physician Burnout
09/28/2026
Raymond Cross, MD; Sara Horst, MD
Hosts Raymond Cross, MD, and Sara Horst, MD, have a frank discussion about the extent of burnout among physicians—including gastroenterologists—including causes, and advice on how to better manage time and work-life balance.
Hosts Raymond Cross, MD, and Sara Horst, MD, have a frank discussion about the extent of burnout among physicians—including gastroenterologists—including causes, and advice on how to better manage time and work-life balance.
Hosts Raymond Cross, MD, and...
09/28/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Rebecca Brown, MD, on Controversies in IBD Surgery
09/15/2026
Raymond Cross, MD; Rebecca Brown, MD
Host Raymond Cross, MD, and colorectal surgeon Rebecca Brown, MD, discuss surgical therapies for Crohn's disease and ulcerative colitis, including controversies about the best approaches.
Host Raymond Cross, MD, and colorectal surgeon Rebecca Brown, MD, discuss surgical therapies for Crohn's disease and ulcerative colitis, including controversies about the best approaches.
Host Raymond Cross, MD, and...
09/15/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Gursimran Kocchar, MD, on Medical and Endoscopic Management of Strictures in Crohn's Disease
08/28/2026
Raymond Cross, MD; Gursimran S. Kochhar
Host Raymond Cross, MD, brings in Dr Gursiman Kocchar to share his expertise in the management of strictures in Crohn's disease, from medical therapies to endoscopic procedures to surgery.
Host Raymond Cross, MD, brings in Dr Gursiman Kocchar to share his expertise in the management of strictures in Crohn's disease, from medical therapies to endoscopic procedures to surgery.
Host Raymond Cross, MD, brings...
08/28/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
Marla Dubinsky, MD, on Lifelong Reproductive Care for Women With IBD
08/05/2026
Raymond Cross, MD; Marla C. Dubinsky, MD
Dr Marla Dubinsky joins host Raymond Cross, MD, for a discussion about how inflammatory bowel disease affects women's reproductive health beyond childbearing, from choosing contraception and using hormonal replacement therapy in perimenopause.
Dr Marla Dubinsky joins host Raymond Cross, MD, for a discussion about how inflammatory bowel disease affects women's reproductive health beyond childbearing, from choosing contraception and using hormonal replacement therapy in perimenopause.
Dr Marla Dubinsky joins host...
08/05/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Dana Lukin, MD, on Ulcerative Proctitis
07/07/2026
Raymond Cross, MD; Dana Lukin, MD
Drs Raymond Cross and Dana Lukin review isolated ulcerative proctitis, including risk factors, diagnosis, mimics, and cancer surveillance.
Drs Raymond Cross and Dana Lukin review isolated ulcerative proctitis, including risk factors, diagnosis, mimics, and cancer surveillance.
Drs Raymond Cross and Dana Lukin...
07/07/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Jennifer Seminerio, MD, on Advanced Combination Therapy
06/12/2026
Raymond Cross, MD; Jennifer Seminerio, MD
Drs Cross and Seminerio discuss advanced combination therapy, which involves use of more than one biologic or a biologic and an advanced small molecule, including trial results to date, types of combinations, safety considerations, and which...
Drs Cross and Seminerio discuss advanced combination therapy, which involves use of more than one biologic or a biologic and an advanced small molecule, including trial results to date, types of combinations, safety considerations, and which...
Drs Cross and Seminerio discuss...
06/12/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Jordan Axelrad, MD, on Communicating Risks to Patients With IBD
05/22/2026
Raymond Cross, MD; Jordan Axelrad, MD
Drs Raymond Cross and Jordan Axelrad provide guidance to clinicians about the best ways to put risks—both of uncontrolled IBD and of therapies—into perspective for patients.
Drs Raymond Cross and Jordan Axelrad provide guidance to clinicians about the best ways to put risks—both of uncontrolled IBD and of therapies—into perspective for patients.
Drs Raymond Cross and Jordan...
05/22/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Colleen Kelly, MD, on Obesity and IBD
04/20/2026
Raymond Cross, MD; Colleen Kelly, MD
Host Raymond Cross, MD, calls on Dr Colleen Kelly to discuss the increasing prevalence of obesity among patients with IBD, how obesity can complicate Crohn's disease and ulcerative colitis, and the role of GLP-1 RAs and bariatric surgery in...
Host Raymond Cross, MD, calls on Dr Colleen Kelly to discuss the increasing prevalence of obesity among patients with IBD, how obesity can complicate Crohn's disease and ulcerative colitis, and the role of GLP-1 RAs and bariatric surgery in...
Host Raymond Cross, MD, calls on...
04/20/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Jared Magee, MD, on Men's Health in IBD
04/07/2026
Raymond Cross, MD; Jared Magee, MD
Drs Raymond Cross and Jared Magee discuss some of the special concerns that affect men with inflammatory bowel disease, from cardiac concerns to sexual dysfunction and assessing for anal cancer.
Drs Raymond Cross and Jared Magee discuss some of the special concerns that affect men with inflammatory bowel disease, from cardiac concerns to sexual dysfunction and assessing for anal cancer.
Drs Raymond Cross and Jared...
04/07/2026
Advances in Inflammatory Bowel Disease Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use